The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Scanning the Immunopathogenesis of Psoriasis
Open accessAbstract
Psoriasis is a chronic inflammatory skin disease, the immunologic model of which has been profoundly revised following recent advances in the understanding of its pathophysiology. In the current model, a crosstalk between keratinocytes, neutrophils, mast cells, T cells, and dendritic cells is thought to create inflammatory and pro-proliferative circuits mediated by chemokines and cytokines. Various triggers, including recently identified autoantigens, Toll-like receptor agonists, chemerin, and thymic stromal lymphopoietin may activate the pathogenic cascade resulting in enhanced production of pro-inflammatory and proliferation-inducing mediators such as interleukin (IL)-17, tumor necrosis factor (TNF)-α, IL-23, IL-22, interferon (IFN)-α, and IFN-γ by immune cells. Among these key cytokines lie therapeutic targets for currently approved antipsoriatic therapies. This review aims to provide a comprehensive overview on the immune-mediated mechanisms characterizing the current pathogenic model of psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Wang, H., Peters, T., Sindrilaru, A., Keß, D., Oreshkova, T., Yu, X., Seier, A. M., Schreiber, H. A., Wlaschek, M., Blakytny, R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34916 · Cited by 67
Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?
Chiricozzi, A., Saraceno, R., Chimenti, M. S., Guttman‐Yassky, E., & Krueger, J. G. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.889686 · Cited by 67
Self-citationCCR6 as a possible therapeutic target in psoriasis
Hedrick, M. N., Lonsdorf, A. S., Hwang, S. T., & Farber, J. M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.504716 · Cited by 65
Watanabe, N., Hanabuchi, S., Marloie-Provost, M.-A., Antonenko, S. V., Liu, Y.-J., & Soumelis, V. (2005) · Blood · doi:10.1182/blood-2004-09-3622 · Cited by 64
CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice
Bagchi, S., He, Y. Z., Zhang, H., Cao, L., Rhijn, I. V., Moody, D. B., Gudjonsson, J. E., & Wang, C.-R. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92217 · Cited by 63
Stromal-cell regulation of dendritic-cell differentiation and function
Svensson, M., & Kaye, P. M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.006 · Cited by 56
IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity
Fotiadou, C., Lazaridou, E., Sotiriou, E., Gerou, S., Kyrgidis, Α., Vakirlis, E., & Ioannides, D. (2015) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475415584503 · Cited by 52
Hahn, M., & Ghoreschi, K. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1279054 · Cited by 50
Th17 Cells Carrying TCR Recognizing Epidermal Autoantigen Induce Psoriasis-like Skin Inflammation
Nishimoto, S., Kotani, H., Tsuruta, S., Shimizu, N., Ito, M., Shichita, T., Morita, R., Takahashi, H., Amagai, M., & Yoshimura, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300348 · Cited by 49
Harden, J. L., Hamm, D. E., Gulati, N., Lowes, M. A., & Krueger, J. G. (2015) · F1000Research · doi:10.12688/f1000research.6756.1 · Cited by 48
CD8+ T Cells Mediate RAS-Induced Psoriasis-Like Skin Inflammation through IFN-γ
Gunderson, A. J., Mohammed, J., Horvath, F. J., Podolsky, M. A., Anderson, C. R., & Glick, A. B. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.390 · Cited by 48
Effects of adalimumab therapy in adult subjects with moderate‐to‐severe psoriasis on Th17 pathway
Balato, A., Schiattarella, M., Caprio, R. D., Lembo, S., Mattii, M., Balato, N., & Ayala, F. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12240 · Cited by 47
Chemokine Receptors in T-Cell-Mediated Diseases of the Skin
Lonsdorf, A. S., Hwang, S. T., & Enk, A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.122 · Cited by 43
Chen, S., de Groot, M., Kinsley, D., Laverty, M., McClanahan, T. K., Arreaza, M. G., Gustafson, E. L., Teunissen, M. B. M., de Rie, M. A., Fine, J. S., et al. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0966-2 · Cited by 42
Perforin expression is upregulated in the epidermis of psoriatic lesions
Kaštelan, M., Massari, L. P., Gruber, F., Zamolo, G., Žauhar, G., Čoklo, M., & Rukavina, D. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06168.x · Cited by 39
Das, P. K., de Boer, O. J., Visser, A., Verhagen, C. E., Bos, J. D., & Pals, S. T. (1994) · PubMed · Cited by 34
Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series
Lowes, M. A., Turton, J. A., Krueger, J. G., & Barnetson, R. S. (2005) · BMC Dermatology · doi:10.1186/1471-5945-5-9 · Cited by 32
Lambert, S., Swindell, W. R., Tsoi, L. C., Stoll, S. W., & Elder, J. T. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.032 · Cited by 32
Kim, C.-H., Kim, J., & Lee, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.010 · Cited by 28
Presentation of lipid antigens to T cells
Mori, L., & Libero, G. D. (2008) · Immunology Letters · doi:10.1016/j.imlet.2007.11.027 · Cited by 28
Tamarozzi, F., Wright, H. L., Thomas, H. B., Edwards, S. W., & Taylor, M. J. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.025 · Cited by 23
Donetti, E., Cornaghi, L., Arnaboldi, F., Landoni, F., Romagnoli, P., Mastroianni, N., Pescitelli, L., Preis, F. W. B., & Prignano, F. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.05.004 · Cited by 21
Prignano, F., Arnaboldi, F., Cornaghi, L., Landoni, F., Tripo, L., Preis, F. W. B., & Donetti, E. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.12.003 · Cited by 16
Relevance of in vitro 3-D skin models in dissecting cytokine contribution to psoriasis pathogenesis.
Chiricozzi, A., Romanelli, M., Panduri, S., Donetti, E., & Prignano, F. (2017) · PubMed · doi:10.14670/hh-11-877 · Cited by 16
Self-citationENDOTHELIAL CELL ADHESION MOLECULES IN PSORIASIS
Lee, M., To, S. S. T., Nicholson, E., & Schrieber, L. (1994) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.1994.tb00898.x · Cited by 13
Neutrophils are not the dominant interleukin‐17 producer in psoriasis
Yamanaka, K., Yamagiwa, A., Akeda, T., Kondo, M., Kakeda, M., Habe, K., Imafuku, S., Sano, S., & Mizutani, H. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13807 · Cited by 12
Interleukin 4 as a potential drug candidate for psoriasis
Weigert, C., Röcken, M., & Ghoreschi, K. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.3.357 · Cited by 11
Chiricozzi, A., Cannizzaro, M. V., Salandri, G., Marinari, B., Pitocco, R., Dattola, A., Regine, F., Saraceno, R., Bianchi, L., Chimenti, S., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13403 · Cited by 8
Self-citation
Cited by
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
Hawkes, J. E., Yan, B. Y., Chan, T. C., & Krueger, J. G. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800013 · Cited by 593
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
Albanesi, C., Madonna, S., Gisondi, P., & Girolomoni, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01549 · Cited by 432
New Treatment Addressing the Pathogenesis of Psoriasis
Tokuyama, M., & Mabuchi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207488 · Cited by 291
Chiang, C.-C., Cheng, W.-J., Korinek, M., Lin, C.-Y., & Hwang, T.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02376 · Cited by 289
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Hammouda, M., Ford, A., Liu, Y., & Zhang, J. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 284
Metadata
- Authors
- Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., & Romanelli, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-01-08
- Volume
- 19
- Issue
- 1
- Pages
- 179
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2783502763
- Cited by
- 320
- References
- 228
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.